Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Gadofosveset
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Vasovist, Ablavar |
Routes of administration |
Intravenous |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG |
|
Chemical and physical data | |
Formula | C33H40GdN3Na3O15P |
Molar mass | 975.88 g·mol−1 |
3D model (JSmol) | |
| |
|
Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It was used as the trisodium salt monohydrate form. It acts as a blood pool agent by binding to human serum albumin. The manufacturer (Lantheus Medical) discontinued production in 2017 due to poor sales.
Gadofosveset facilitates high-resolution magnetic resonance angiography. Ferumoxytol (trade names Feraheme, Rienso), an intravenous iron-replacement therapy, has been shown to potentially be superior to gadofosveset as a blood pool agent for MR venography in pediatric patients.
X-ray and CT |
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRI |
|
||||||||||||
Ultrasound |
|
||||||||||||
|